Company Spotlight – Precede Bio
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Now Available: Spotlight on Attovia CEO Tao Fu. Click here to read.
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Lightcast controls microdroplets with light to create a fast, flexible experimental platform.
SonoThera’s novel technology could unleash new genetic medicines with expanded patient access.
Developing protein therapies is a numbers game. For every one molecule that safely and effectively treats a specific condition, billions of alternatives need to be sifted through to find it. This painstakingly slow and iterative process can take months or even years.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.